In this video, health-care analysts David Williamson and Max Macaluso discuss the recent 20% plunge suffered by Edwards Lifesciences investors and whether the factors behind the substantial revenue miss make the stock a bad news buy or if investors will be cut trying to catch a falling knife.
We all would like to build long-term wealth and retire well, but buying stocks after a sudden plunge isn't a surefire strategy. In our free report "3 Stocks That Will Help You Retire Rich," we reveal some stocks that could help you as well as some winning wealth-building strategies. Click here to keep reading.
